Can anti-IgE be used to treat allergy?

Springer Seminars in Immunopathology

Volumn 15, Issue 1, 1993, Pages 51-73

  Davis, F M ^a   Gossett, L A ^a   Pinkston, K L ^a   Liou, R S ^a   Sun, L K ^a   Kim, Y W ^a   Chang, N T ^a   Chang, T W ^a   Wagner, K ^b   Bews, J ^b   Brinkmann, V ^b   Towbin, H ^b   Subramanian, N ^b   Heusser, C ^b  

^a Tanox Biosystems Inc   (United States)

^b CIBA GEIGY LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CGP 51901; ENDOGENOUS COMPOUND; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ALLERGY; ANTIGEN ANTIBODY COMPLEX; B LYMPHOCYTE; CONFERENCE PAPER; HISTAMINE RELEASE; HUMAN; PRIORITY JOURNAL;

ANIMAL; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; HUMAN; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; MICE; MICE, INBRED BALB C;

EID: 0027155071     PISSN: 03444325     EISSN: 14322196     Source Type: Journal    
DOI: 10.1007/BF00204626     Document Type: Article

References (54)

1. Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay
2. Interleukin 4 instructs uncommitted B lymphocytes to switch to IgG1 and IgE
3. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies
4. Association of asthma with serum IgE levels and skin-test reactivity to allergens
5. Monoclonal antibodies specific for IgE-secreting B lymphocytes
6. Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases
7. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-γ
8. An epitope on membrane-bound but not secreted IgE: implications in isotype-specific regulation
9. Human IgE-binding factors
10. Antibody-mediated (immediate-type) hypersensitivity
11. Suppression of in vivo polyclonal IgE response by monoclonal antibody to the lymphocyte B cell stimulatory factor-1
12. Lymphokine control of in vivo immunoglobulin isotype selection
13. Immediate hypersensitivity
14. Histamine release from human leukocytes: studies with deuterium oxide, colchicine and cytochalasin B
15. CD23: a multifunctional receptor/lymphokine?
16. Inhibition of IgE synthesis by anti-IgE: role in long-term inhibition of IgE synthesis by neonatally administered soluble IgE
17. New concepts of IgE regulation
18. The nucleotide sequence of the mouse immunoglobulin epsilon gene: comparison with the human epsilon gene sequence
19. IgE-binding factors and regulation of the IgE antibody response
20. Allergy
21. Activation of mast cells for mediator release through IgE receptors
22. IL-4 requirements for the generation of secondary in vivo IgE responses
23. Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans
24. Generation and analysis of IL-4 deficient mice
25. Healthy IgE-deficient person
26. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors
27. A chimeric mouse-human antibody that retains specificity for HIV gp120 and mediates the lysis of HIV-infected cells
28. Mouse/human chimeric monoclonal antibody in man: kinetics and immune response
29. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links
30. Clinical significance of anti-IgE autoantibodies and immune complexes containing IgE
31. Induction of an auto-anti-IgE response in rats. I. Effects on serum IgE concentrations
32. The receptor with high affinity for immunoglobulin E
33. Parasites and allergy: evidence for a “cause and effect” relationship
34. National Asthma Education Program, Expert Panel Report. Guidelines for the diagnosis and management of asthma. IV. Overview of approaches to asthma therapy
35. B-cell stimulatory factor-I/interleukin 4
36. Immediate hypersensitivity
37. Studies of the IgE binding site to rat mast cell receptor with proteolytic fragments and with a monoclonal antibody directed against epsilon heavy chain: evidence that the combining sites are located in the Cɛ3 domain
38. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon-gamma-independent mechanism
39. Nucleotide sequences of immunoglobulin genes of chimpanzee and orangutan: DNA molecular clock and hominid evolution
40. Phase I trial of the chimeric anti-GD2 monoclonal antibody ch 14.18 in patients with malignant melanoma
41. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children
42. Mast cells and basophils
43. Histamine-release and assay methods for the study of human allergy
44. Alpha-interferon treatment of a patient with hyper IgE syndrome
45. Structure and function of Fc receptors for IgE on lymphocytes, monocytes, and macrophages
46. Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity
47. Transfectomas expressing both secreted and membrane-bound forms of chimeric IgE with anti-viral specificity
48. A survey of nonatopic and atopic children and adults for the presence of anti-IgE autoantibodies
49. Generation and cloning of stable human IgE-secreting cells that have rearranged the Cɛ gene
50. Interaction of human IgG chimeric antibodies with the human FcRI and FcRII receptors: requirements for antibody-mediated host cell-target cell interaction
51. Man-made antibodies